Drug recall · July 3, 2019
Riboflavin 5-Phosphate Sodium Ophthalmic Solution recall
Why: Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Riboflavin 5-Phosphate Sodium Ophthalmic Solution, 19.05mg/3mL (6.35 mg/mL), 3 mL Dropper Bottle, Rx only, Premier Pharmacy Labs, 8265 Commercial Way, Weeki Wachee, FL 34613, NDC: 69623-106-61, barcode 1 69623 10661 9.
- Lots / codes
All lots remaining within expiry.
- Quantity
- 125 dropper bottles
- Company
- Premier Pharmacy Labs Inc, Weeki Wachee, FL
- Distribution
- Nationwide in the USA
- Initiated
- June 18, 2019 · Voluntary: Firm initiated
- Classified
- June 21, 2019
- Reported
- July 3, 2019
- Ended
- October 26, 2021
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.